AXL and colorectal cancer: It was found that the biomarkers of efferocytosis (AXL, CD36, UCP2) and macrophage repair indicators SPMs (RvD1, RvE1, LipoxinA4) were significantly increased in animal models and postoperative colorectal cancer patients.